Dumont & Blake Investment Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.53M | Sell |
19,167
-74
| -0.4% | -$5.91K | 0.4% | 70 |
|
|
2025
Q1 | $1.67M | Sell |
19,241
-114
| -0.6% | -$9.87K | 0.47% | 59 |
|
|
2024
Q4 | $1.6M | Sell |
19,355
-188
| -1% | -$15.5K | 0.43% | 65 |
|
|
2024
Q3 | $1.7M | Sell |
19,543
-19,932
| -50% | -$1.73M | 0.45% | 62 |
|
|
2024
Q2 | $3.25M | Buy |
39,475
+19,874
| +101% | +$1.63M | 0.46% | 58 |
|
|
2024
Q1 | $1.57M | Sell |
19,601
-164
| -0.8% | -$13.1K | 0.45% | 59 |
|
|
2023
Q4 | $1.5M | Sell |
19,765
-709
| -3% | -$54K | 0.47% | 54 |
|
|
2023
Q3 | $1.48M | Sell |
20,474
-44
| -0.2% | -$3.19K | 0.5% | 51 |
|
|
2023
Q2 | $1.55M | Sell |
20,518
-240
| -1% | -$18.2K | 0.5% | 52 |
|
|
2023
Q1 | $1.58M | Buy |
20,758
+76
| +0.4% | +$5.78K | 0.53% | 51 |
|
|
2022
Q4 | $1.63M | Sell |
20,682
-329
| -2% | -$25.9K | 0.58% | 49 |
|
|
2022
Q3 | $1.5M | Sell |
21,011
-226
| -1% | -$16.1K | 0.56% | 49 |
|
|
2022
Q2 | $1.59M | Buy |
21,237
+6
| +0% | +$450 | 0.52% | 54 |
|
|
2022
Q1 | $1.69M | Buy |
21,231
+520
| +3% | +$41.4K | 0.46% | 55 |
|
|
2021
Q4 | $1.68M | Buy |
20,711
+491
| +2% | +$39.8K | 0.44% | 60 |
|
|
2021
Q3 | $1.56M | Buy |
20,220
+570
| +3% | +$44.1K | 0.45% | 61 |
|
|
2021
Q2 | $1.58M | Buy |
19,650
+63
| +0.3% | +$5.07K | 0.45% | 65 |
|
|
2021
Q1 | $1.55M | Buy |
19,587
+666
| +4% | +$52.5K | 0.47% | 60 |
|
|
2020
Q4 | $1.35M | Buy |
18,921
+361
| +2% | +$25.8K | 0.46% | 62 |
|
|
2020
Q3 | $1.19M | Buy |
18,560
+1,343
| +8% | +$85.7K | 0.45% | 64 |
|
|
2020
Q2 | $1.11M | Buy |
17,217
+326
| +2% | +$21.1K | 0.47% | 62 |
|
|
2020
Q1 | $929K | Sell |
16,891
-374
| -2% | -$20.6K | 0.48% | 59 |
|
|
2019
Q4 | $1.12M | Buy |
17,265
+471
| +3% | +$30.5K | 0.44% | 70 |
|
|
2019
Q3 | $952K | Buy |
16,794
+935
| +6% | +$53K | 0.4% | 79 |
|
|
2019
Q2 | $954K | Sell |
15,859
-235
| -1% | -$14.1K | 0.4% | 77 |
|
|
2019
Q1 | $1.05M | Buy |
16,094
+30
| +0.2% | +$1.96K | 0.44% | 68 |
|
|
2018
Q4 | $1M | Sell |
16,064
-1,516
| -9% | -$94.6K | 0.47% | 67 |
|
|
2018
Q3 | $1.29M | Buy |
17,580
+1,555
| +10% | +$114K | 0.5% | 58 |
|
|
2018
Q2 | $1.08M | Buy |
16,025
+635
| +4% | +$42.7K | 0.45% | 71 |
|
|
2018
Q1 | $960K | Buy |
15,390
+40
| +0.3% | +$2.5K | 0.41% | 86 |
|
|
2017
Q4 | $985K | Buy |
15,350
+180
| +1% | +$11.6K | 0.4% | 90 |
|
|
2017
Q3 | $991K | Buy |
15,170
+360
| +2% | +$23.5K | 0.42% | 85 |
|
|
2017
Q2 | $930K | Buy |
14,810
+440
| +3% | +$27.6K | 0.41% | 88 |
|
|
2017
Q1 | $844K | Buy |
14,370
+190
| +1% | +$11.2K | 0.38% | 92 |
|
|
2016
Q4 | $795K | Sell |
14,180
-25
| -0.2% | -$1.4K | 0.37% | 93 |
|
|
2016
Q3 | $876K | Buy |
14,205
+75
| +0.5% | +$4.63K | 0.43% | 89 |
|
|
2016
Q2 | $895K | Buy |
+14,130
| New | +$895K | 0.45% | 83 |
|